NEW YORK, February 10, 2026--(BUSINESS WIRE)--Orbus Software ®, a leading global provider of enterprise transformation solutions, today announced that OrbusInfinity ® Government, its cloud-native ...

Orbus Software®, a leading global provider of enterprise transformation solutions, today announced that OrbusInfinity ® Government, its cloud-native platform built for the US public sector, has ...

NEW YORK--(BUSINESS WIRE)--Orbus Software ®, a leading global provider of enterprise transformation solutions, today announced that OrbusInfinity ® Government, its cloud-native platform built for the ...

OrbusInfinity Government provides Federal agencies with a secure enterprise architecture platform that delivers a unified, data-driven view of their business and technology landscape. The platform ...

Abstract: Smart hospital transformation in hospitals is currently needed to increase hospital services' effectiveness and efficiency. One of the smart hospital implementations is the use of SIM RS ...

The STELLAR Phase 3 clinical trial found that a new treatment approach helped people with a tough-to-treat brain cancer, called grade 3 astrocytoma, live longer. The new treatment is a major step ...

LONDON, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Orbus Software, a leading global provider of enterprise transformation software, today announced the appointment of Steve Fulton as CEO. He succeeds former ...

– Updated results based on molecular classification and blinded independent central review demonstrate clinically meaningful survival benefits for patients with recurrent grade 3 astrocytoma who were ...

Eflornithine is a novel cytostatic agent that irreversibly inhibits ornithine decarboxylase, a key enzyme in mammalian polyamine biosynthesis that is upregulated in certain types of cancer.